Discover 3,561 paid clinical trials in Costa Mesa, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,561
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
for
Urothelial Carcinoma Bladder,
Location: Irvine CA, Duarte CA, Salt Lake City UT, Westwood KS,
Sponsor: Aktis Oncology, Inc.
Sex: All
Age: 18+
Code: NCT07020117
Phase1, Recruiting
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
for
Refractory Rheumatoid Arthritis (RA),
Location: Santa Ana CA, Tustin CA, Los Alamitos CA, Covina CA,
Sponsor: Artiva Biotherapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06991114
Phase2, Recruiting
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
for
Asthma
Location: Westminster CA, Orange CA, Mission Viejo CA,
Sponsor: AstraZeneca
Sex: All
Age: 12 - 17
Code: NCT06307665
Phase3, Recruiting
Sample Collection Study for the CellMax Life Circulating Tumor Cell and Circulating Tumor DNA Platforms for the Early Detection of Colorectal Cancer and Adenomas
for
Colorectal Cancer Screening
Location: Tustin CA, Lancaster CA, Chula Vista CA, San Antonio TX,
Sponsor: CellMax Life
Sex: All
Age: 45 - 70+
Code: NCT05127096
Recruiting
A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
for
Lupus Nephritis, Primary Membranous Nephropathy
Location: Tustin CA, Ann Arbor MI, Stony Brook NY, Dallas TX,
Sponsor: Nkarta, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06557265
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)
for
Complex Regional Pain Syndrome Type I
Location: Tustin CA, Pasadena CA, La Jolla CA, Phoenix AZ,
Sponsor: Ambros Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07210515
Phase3, Recruiting
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata